Jocelyn Theresa Kuryan, MD | |
319 2nd Street Pike, Southampton, PA 18966-3811 | |
(215) 355-4428 | |
(215) 355-0790 |
Full Name | Jocelyn Theresa Kuryan |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 18 Years |
Location | 319 2nd Street Pike, Southampton, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386964989 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207WX0120X | Ophthalmology - Cornea And External Diseases Specialist | MD443789 (Pennsylvania) | Secondary |
207W00000X | Ophthalmology | MD443789 (Pennsylvania) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tri-century Eye Care, P.c. | 3173416237 | 18 |
News Archive
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Tobacco manufacturers are offering retailers incentives to promote their products in a bid to mitigate the effects of the advertising ban, a University of Stirling study has found.
Altering the standard step-by-step procedure that takes women facing a mastectomy from diagnosis to surgery to reconstruction can improve the process and help in determining if immediate reconstruction is the best course of action, according to new research from the University of North Carolina at Chapel Hill.
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.
CryoLife has announced that it has been awarded a patent by the U.S. Patent Office for BioFoam, a protein hydrogel foam for rapidly filling and sealing open wounds.
› Verified 6 days ago
Entity Name | Tri-century Eye Care, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336154087 PECOS PAC ID: 3173416237 Enrollment ID: O20040204000167 |
News Archive
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Tobacco manufacturers are offering retailers incentives to promote their products in a bid to mitigate the effects of the advertising ban, a University of Stirling study has found.
Altering the standard step-by-step procedure that takes women facing a mastectomy from diagnosis to surgery to reconstruction can improve the process and help in determining if immediate reconstruction is the best course of action, according to new research from the University of North Carolina at Chapel Hill.
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.
CryoLife has announced that it has been awarded a patent by the U.S. Patent Office for BioFoam, a protein hydrogel foam for rapidly filling and sealing open wounds.
› Verified 6 days ago
Entity Name | Tri County Surgery Center Llc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1649375452 PECOS PAC ID: 6608893847 Enrollment ID: O20051027000649 |
News Archive
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Tobacco manufacturers are offering retailers incentives to promote their products in a bid to mitigate the effects of the advertising ban, a University of Stirling study has found.
Altering the standard step-by-step procedure that takes women facing a mastectomy from diagnosis to surgery to reconstruction can improve the process and help in determining if immediate reconstruction is the best course of action, according to new research from the University of North Carolina at Chapel Hill.
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.
CryoLife has announced that it has been awarded a patent by the U.S. Patent Office for BioFoam, a protein hydrogel foam for rapidly filling and sealing open wounds.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Jocelyn Theresa Kuryan, MD 319 2nd Street Pike, Southampton, PA 18966-3811 Ph: (215) 355-4428 | Jocelyn Theresa Kuryan, MD 319 2nd Street Pike, Southampton, PA 18966-3811 Ph: (215) 355-4428 |
News Archive
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Tobacco manufacturers are offering retailers incentives to promote their products in a bid to mitigate the effects of the advertising ban, a University of Stirling study has found.
Altering the standard step-by-step procedure that takes women facing a mastectomy from diagnosis to surgery to reconstruction can improve the process and help in determining if immediate reconstruction is the best course of action, according to new research from the University of North Carolina at Chapel Hill.
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.
CryoLife has announced that it has been awarded a patent by the U.S. Patent Office for BioFoam, a protein hydrogel foam for rapidly filling and sealing open wounds.
› Verified 6 days ago
Dr. Richard B Prince, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 319 2nd Street Pike, Southampton, PA 18966 Phone: 215-355-4428 Fax: 215-355-0790 | |
Dr. Scott M Goldstein, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 319 2nd Street Pike, Southampton, PA 18966 Phone: 215-355-4428 Fax: 215-355-0790 | |
Dr. Jeffrey A Gordon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 319 2nd Street Pike, Southampton, PA 18966 Phone: 215-355-4428 Fax: 215-355-0790 | |
Dr. Mona Lisa Nedjar, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 319 2nd Street Pike, Southampton, PA 18966 Phone: 215-355-4428 Fax: 215-355-0790 | |
Dr. Sheryl J Menacker, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 319 2nd Street Pike, Southampton, PA 18966 Phone: 215-355-4428 Fax: 215-355-0790 | |
Dr. Richard L Tax, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 319 2nd Street Pike, Southampton, PA 18966 Phone: 215-355-4428 Fax: 215-355-0790 |